Home › Funds › Norges Bank Investment Management › DNLI
Norges Bank Investment Management position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)2.82M sh
Reported value held$72.65M
Portfolio Weight0.01%
First reportedQ4 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 1.02M | $28.48M | New |
| Q4 2023 | 1.15M | $24.74M | Add |
| Q2 2024 | 823.94K | $19.13M | Reduce |
| Q4 2024 | 1.07M | $21.72M | Add |
| Q2 2025 | 3.95M | $55.22M | Add |
| Q4 2025 | 5.12M | $84.52M | Add |
| Q2 2026 | 2.82M | $72.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026